Andrew Huberman· PhD
And that company can now do this at industrial scale. It takes patient cells, electroparates them, and has now written a long piece of like 10 10,000 nucleotides of DNA code that put in a sequence of a combination of different receptors, including a car and additional gene enhancements that will make these tea cells more powerful in in in a tumor micro environment.